Barely Significant

Excerpts

514,629 sentences

highly significantp = 0.0040.1× alphaqualifiedgold
The individuals living in Cochran and Bailey Counties had high likely to have cognitively impaired (AOR: 1.807, 95% CI: (0.749, 4.360), p = 0.188; AOR: 1.674, 95% CI: (0.267, 10.489), p = 0.582) though the adjusted odds ratios are not statistically significant, on the other hand Parmer County had the highest cognitively impaired individuals (AOR: 39.188, 95% CI: (3.123, 491.671) and this adjusted odds ratio is statistically highly significant ( p = 0.004).
highly significantP value = .0040.1× alphaqualifiedgold
As Kadi et al showed in their review, the effects of satellite cell activation take approximately 50-90 days to propagate fully, which corresponds to our 2-month follow-up observation, when the increase of muscle fibers was found to be highly significant when compared to the control group ( P value = .004). 35 Nonetheless, all markers increased gradually in the active group and no significant changes were observed in the control group, and we can attribute the results seen in the active group to the HIFES + RF sessions.
highly significantp=0.0040.1× alphaqualifiedgold
Further adjustment for gestational age at birth, sociodemographic factors, comorbidities and parental history of IHD resulted in a moderately attenuated risk estimate that remained highly significant (fully adjusted HR for <−2 SD vs −1 to <1 SD, 1.54; 95% CI 1.15 to 2.07; p=0.004), and an inverse trend remained across the full range of fetal growth (fully adjusted HR per additional 1 SD, 0.93; 95% CI 0.87 to 0.99; p=0.04) ( table 1 , adjusted model 2).
Additionally, although TAS levels appeared higher in the LPS+NEB group compared to the LPS group, this difference did not reach statistical significance. Moreover, TAS levels showed a significant increase in the NEB group compared to the LPS group ( p = 0.004).
nominally significantP = 0.0040.1× alphagold
Impact of pridopidine on global clinical progression (cUHDRS) In the mITT population off ADMs, pridopidine showed nominally significant benefits in maintaining cUHDRS scores compared with placebo, with the largest differences (Δ) at week 26 (Δ = 0.46, P = 0.004; placebo n = 112, pridopidine n = 95), week 39 (Δ = 0.45, P = 0.014; placebo n = 107, pridopidine n = 90) and week 52 (Δ = 0.41, P = 0.035; placebo n = 104, pridopidine n = 91) (Fig. 3a ).